This Is A Custom Widget

This Sliding Bar can be switched on or off in theme options, and can take any widget you throw at it or even fill it with your custom HTML Code. Its perfect for grabbing the attention of your viewers. Choose between 1, 2, 3 or 4 columns, set the background color, widget divider color, activate transparency, a top border or fully disable it on desktop and mobile.

This Is A Custom Widget

This Sliding Bar can be switched on or off in theme options, and can take any widget you throw at it or even fill it with your custom HTML Code. Its perfect for grabbing the attention of your viewers. Choose between 1, 2, 3 or 4 columns, set the background color, widget divider color, activate transparency, a top border or fully disable it on desktop and mobile.

Re-Check’s info-stream: investigations, analyses, comments

Here and on social media

17 17 October 2017

Isotretinoin: health system failures

By | October 17th, 2017|Categories: Isotretinoin - Roaccutane®|0 Comments

Do not miss Wednesday, October 18, 2017 the broadcast in French on RTS (the program is “36,9”) of Serena Tinari’s investigative report about a case involving isotretinoin (*). Serena Tinari’s stunning story was first broadcasted in Italian on RSI channel in February 2017. It reveals a tragic affair: the birth in Switzerland of a girl with [...]

4 4 September 2017

Winding back the harms of too much medicine: Re-Check joined the 5th Preventing Overdiagnosis Conference in Québec City

By | September 4th, 2017|Categories: Adverse effects - Effets indésirables, Approvals - Homologations, Breast cancer screening - Dépistage du cancer du sein, Clinical trials - Essais cliniques, Endometriosis - Endométriose, HPV - HPV/VPH, HPV vaccine - Vaccination anti-HPV, Overdiagnosis - Surdiagnostic|0 Comments

Catherine Riva of Re-Check was selected by the organizers of the Conference to present the results of her investigation on the “mammo-business”, an extensive system of business models and careers building grown in Switzerland around mammography screening. Her long-form investigative piece was honored in 2014 with a Media Award of the Swiss Academies of Medical Sciences. [...]

17 17 June 2017

The crossroads between Evidence Based Medicine and investigation

By | June 17th, 2017|Categories: Training - Enseignement|0 Comments

The crossroads between Evidence Based Medicine and investigation: Re-Check training day in Fribourg (Switzerland) With Catherine Riva and Serena Tinari (Re-Check), Thomas Angeli (Lobbywatch), Manolo Luppichini (reporter) and Prof. Thierry Buclin (Division de toxicologie et de pharmacologie clinique, CHUV, Lausanne).

15 15 June 2017

Overkill?

By | June 15th, 2017|Categories: Genetics - Génétique, Guest author - Auteur invité, HPV - HPV/VPH|0 Comments

By Abby Lippman, Professor Emerita, Department of Epidemiology, Biostatistics and Occupational Health, McGill University; Research Associate, Simone de Beauvoir Institute, Concordia University Published on bioethiqueonline.ca, 14 Jun 2017 Sometimes, perhaps too often, a “bad idea this way comes” and one of the latest is not just “bad” but rather horrifying to me — and perhaps to [...]

2 2 April 2017

HPV testing: big business

By | April 2nd, 2017|Categories: Conflict of interest - Conflits d’intérêts, HPV testing - Typage de HPV, Overdiagnosis - Surdiagnostic|0 Comments

HPV testing is now recommended in several countries (In Holland and USA, for example) to replace the Pap test (cytology) for primary screening of cervical cancer. Roche is one of the big players in this field with its cobas® HPV test. The marketing of the new version was announced on March 28, 2017. The market of [...]